NCEH1-dependent ADPL signal was almost entirely localized to the ovarian cancer cells relative to CD45+ cells, quantified as an ~20-fold and ~7-fold increase in raw and area-normalized NCEH1 ADPL activity, respectively (Fig. 6a, b; Supplementary Fig. 7). This evidence concerns the gene PTPRC and ovarian cancer.